William Reed
Dermatology · Jefferson Valley, NYNPI 1336281963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.
Across 235 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$889
- Incyte Corporation$652
- Sanofi$641
- Johnson & Johnson$288
- GSK$206
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,90196%
- Education$1784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,003 |
| Regeneron Healthcare Solutions, Inc. | 28 | $889 |
| Incyte Corporation | 38 | $652 |
| Sanofi | 26 | $641 |
| Johnson & Johnson | 12 | $288 |
| GSK | 13 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $189 |
| UCB, Inc. | 6 | $128 |
| Sun Pharmaceutical Industries Inc. | 6 | $115 |
| Pfizer | 5 | $108 |
| LEO Pharma Inc. | 6 | $105 |
| Amgen | 5 | $101 |
| Novartis | 4 | $97 |
| Lilly USA, LLC | 3 | $78 |
| Galderma Laboratories, L.p. | 4 | $76 |
| Dermavant Sciences, Inc. | 3 | $66 |
| Organon | 3 | $64 |
| CSL Behring | 4 | $62 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Grifols USA, LLC | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$358
How this compares
$5,079 in reported general payments places this provider in the 60th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 16 | $58,333 |
| XolairOmalizumab | 13 | $35,947 |
| Triamcinolone Acetonide | 40 | $4,683 |
| Clobetasol Propionate | 33 | $3,090 |
| Tacrolimus | 12 | $2,868 |
| Zafirlukast | 13 | $1,654 |
| Doxycycline Hyclate | 24 | $1,473 |
| Tretinoin | 16 | $1,444 |
| Clindamycin Phosphate | 11 | $1,363 |
| Gentamicin Sulfate | 26 | $1,143 |
| Ciclopirox | 18 | $375 |
| Ammonium Lactate | 11 | $178 |
| Mupirocin | 23 | $155 |
| Hydrocortisone | 31 | $138 |
| Famotidine | 14 | $117 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Jefferson Valley
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.